Effects of dimethyl fumarate on neuroprotection and immunomodulation

Journal of Neuroinflammation

Volumn 9, Issue , 2012, Pages

  Albrecht, Philipp ^a   Bouchachia, Imane ^a   Goebels, Norbert ^a   Henke, Nadine ^a   Hofstetter, Harald H ^a   Issberner, Andrea ^a   Kovacs, Zsuzsa ^a   Lewerenz, Jan ^b   Lisak, Dmitrij ^a   Maher, Pamela ^c   Mausberg, Anne Kathrin ^a   Quasthoff, Kim ^a   Zimmermann, Corinna ^a   Hartung, Hans Peter ^a   Methner, Axel ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Dimethyl fumarate; Neuromodulation; Neuroprotection; Oxidative stress

Indexed keywords

CYTOKINE; FUMARIC ACID DERIVATIVE; FUMARIC ACID DIMETHYL ESTER; FUMARIC ACID METHYL ESTER; GLUTATHIONE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; C57BL 6 MOUSE; CELL DEATH; CELL INTERACTION; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EMBRYO; ENZYME LINKED IMMUNOSPOT ASSAY; GENE EXPRESSION; GLUTATHIONE METABOLISM; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MOUSE; NERVE FUNCTION; NEUROPROTECTION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; OXIDATIVE STRESS; PROTEIN CONTENT; SPLEEN CELL;

EID: 84863426841     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-9-163     Document Type: Article

References (19)

1. Compston A, Coles A. Multiple sclerosis. Lancet 2008, 372:1502-1517.
2. Gonsette RE. Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity. J Neurol Sci 2008, 274:48-53. 10.1016/j.jns.2008.06.029, 18684473.
3. Nave K-A, Trapp BD. Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 2008, 31:535-561. 10.1146/annurev.neuro.30.051606.094309, 18558866.
4. Kappos L, Gold R, Miller DH, MacManus DG, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yoursry TA, Yang M, Eraksoy M, Meluzinova E, Rektor I, Dawson KT, Sandrock AW, O'Neill GN, . bg-12 Phase IIb Study Investigators Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet 2008, 372:1463-1472. 10.1016/S0140-6736(08)61619-0, 18970976, bg-12 Phase IIb Study Investigators.
5. Gold R, Kappos L, Bar-Or D, Arnold D, Giovannoni G, Selmaj K, Yang M, Dawson K. Clinical efficacy of BG-12, an oral therapy, in relapsing-remitting multiple sclerosis: data from the phase 3 DEFINE trial 2011, Amsterdam, 17:S9-S52.
6. Vandermeeren M, Janssens S, Wouters H, Borghmans I, Borgers M, Beyaert R, Geysen J. Dimethylfumarate is an inhibitor of cytokine-induced nuclear translocation of NF-kappa B1, but not RelA in normal human dermal fibroblast cells. J Invest Dermatol 2001, 116:124-130. 10.1046/j.1523-1747.2001.00211.x, 11168807.
7. Treumer F, Zhu K, Gläser R, Mrowietz U. Dimethylfumarate is a potent inducer of apoptosis in human T cells. J Invest Dermatol 2003, 121:1383-1388. 10.1111/j.1523-1747.2003.12605.x, 14675187.
8. de Jong R, Bezemer AC, Zomerdijk TP, van de Pouw-Kraan T, Ottenhoff TH, Nibbering PH. Selective stimulation of T helper 2 cytokine responses by the anti-psoriasis agent monomethylfumarate. Eur J Immunol 1996, 26:2067-2074. 10.1002/eji.1830260916, 8814248.
9. Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R, Bista P, Zeng W, Hronowsky X, Buko A, Chollate S, Ellrichmann G, Brück W, Dawson K, Goelz S, Wiese S, Scannevin RH, Lukashev M, Gold R. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 2011, 134:678-692. 10.1093/brain/awq386, 21354971.
10. Lin SX, Lisi L, Russo Dello C, Polak PE, Sharp A, Weinberg G, Kalinin S, Feinstein DL. The anti-inflammatory effects of dimethyl fumarate in astrocytes involve glutathione and haem oxygenase-1. ASN Neuro 2011, 3:75-84.
11. Thiessen A, Schmidt MM, Dringen R. Fumaric acid dialkyl esters deprive cultured rat oligodendroglial cells of glutathione and upregulate the expression of heme oxygenase 1. Neurosci Lett 2010, 475:56-60. 10.1016/j.neulet.2010.03.048, 20347008.
12. Schmidt MM, Dringen R. Fumaric acid diesters deprive cultured primary astrocytes rapidly of glutathione. Neurochem Int 2010, 57:460-467. 10.1016/j.neuint.2010.01.006, 20096739.
13. Albrecht P, Lewerenz J, Dittmer S, Noack R, Maher P, Methner A. Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target. CNS Neurol Disord Drug Targets 2010, 9:373-382.
14. Steinbeck JA, Henke N, Opatz J, Gruszczynska-Biegala J, Schneider L, Theiss S, Hamacher N, Steinfarz B, Golz S, Brüstle O, Kuznicki J, Methner A. Store-operated calcium entry modulates neuronal network activity in a model of chronic epilepsy. Exp Neurol 2011, 232:185-194. 10.1016/j.expneurol.2011.08.022, 21906591.
15. Lewerenz J, Albrecht P, Tien M-LT, Henke N, Karumbayaram S, Kornblum HI, Wiedau-Pazos M, Schubert D, Maher P, Methner A. Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro. J Neurochem 2009, 111:332-343. 10.1111/j.1471-4159.2009.06347.x, 19694903.
16. Hofstetter HH, Lühder F, Toyka KV, Gold R. IL-17 production by thymocytes upon CD3 stimulation and costimulation with microbial factors. Cytokine 2006, 34:184-197. 10.1016/j.cyto.2006.04.014, 16815032.
17. Loewe R, Holnthoner W, Gröger M, Pillinger M, Gruber F, Mechtcheriakova D, Hofer E, Wolff K, Petzelbauer P. Dimethylfumarate inhibits TNF-induced nuclear entry of NF-kappa B/p65 in human endothelial cells. J Immunol 2002, 168:4781-4787.
18. Gramowski A, Jügelt K, Stüwe S, Schulze R, McGregor GP, Wartenberg-Demand A, Loock J, Schröder O, Weiss DG. Functional screening of traditional antidepressants with primary cortical neuronal networks grown on multielectrode neurochips. Eur J Neurosci 2006, 24:455-465. 10.1111/j.1460-9568.2006.04892.x, 16903853.
19. Ghoreschi K, Bruck J, Kellerer C, Deng C, Peng H, Rothfuss O, Hussain RZ, Gocke AR, Respa A, Glocova I, Valtcheva N, Alexander E, Feil S, Feil R, Schulze-Osthoff K, Rupec RA, Lovett-Racke AE, Dringen R, Racke MK, Röcken M. Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells. J Exp Med 2011, 208:2291-2303. 10.1084/jem.20100977, 3201195, 21987655.